Patient characteristics of 1:1 NNM with a 0.2 caliper cutoff of patients at MER to those at MSK
| Characteristic . | Full MSK cohort with GCB and non-GCB subtype (n = 138) . | MSK subset with available matches (n = 108) . | MER propensity score–matched cohort (n = 108) . |
|---|---|---|---|
| Age at diagnosis (y) | |||
| Median (range) | 54 (21-71) | 55 (22-71) | 54 (20-71) |
| Q1, Q3 | 45, 62 | 45, 62 | 45, 64 |
| Male | 76/138 (55%) | 62/108 (57%) | 59/108 (55%) |
| Female | 62/138 (45%) | 46/108 (43%) | 49/108 (45%) |
| aaIPI score | |||
| aaIPI LIR | 25/138 (18%) | 25/108 (23%) | 29/108 (27%) |
| HIR | 80/138 (58%) | 69/108 (64%) | 66/108 (61%) |
| HR | 33/138 (24%) | 14/108 (13%) | 13/108 (12%) |
| COO GCB | 69/138 (50%) | 56/108 (52%) | 55/108 (51%) |
| Non-GCB | 69/138 (50%) | 52/108 (48%) | 53/108 (49%) |
| DTI (d) | |||
| Median (range) | 21 (1-77) | 21 (1-54) | 15 (2-109) |
| Q1, Q3 | 14, 28 | 14, 28 | 8, 29 |
| Year of diagnosis | 2002-2013 | 2002-2013 | 2002-2014 |
| Characteristic . | Full MSK cohort with GCB and non-GCB subtype (n = 138) . | MSK subset with available matches (n = 108) . | MER propensity score–matched cohort (n = 108) . |
|---|---|---|---|
| Age at diagnosis (y) | |||
| Median (range) | 54 (21-71) | 55 (22-71) | 54 (20-71) |
| Q1, Q3 | 45, 62 | 45, 62 | 45, 64 |
| Male | 76/138 (55%) | 62/108 (57%) | 59/108 (55%) |
| Female | 62/138 (45%) | 46/108 (43%) | 49/108 (45%) |
| aaIPI score | |||
| aaIPI LIR | 25/138 (18%) | 25/108 (23%) | 29/108 (27%) |
| HIR | 80/138 (58%) | 69/108 (64%) | 66/108 (61%) |
| HR | 33/138 (24%) | 14/108 (13%) | 13/108 (12%) |
| COO GCB | 69/138 (50%) | 56/108 (52%) | 55/108 (51%) |
| Non-GCB | 69/138 (50%) | 52/108 (48%) | 53/108 (49%) |
| DTI (d) | |||
| Median (range) | 21 (1-77) | 21 (1-54) | 15 (2-109) |
| Q1, Q3 | 14, 28 | 14, 28 | 8, 29 |
| Year of diagnosis | 2002-2013 | 2002-2013 | 2002-2014 |
aaIPI, age-adjusted International Prognostic Index; COO, cell of origin; DTI, diagnosis to treatment interval; HIR, high-intermediate risk; HR, high risk; GCB, germinal center B-cell-like LIR, low-intermediate risk; MER, Molecular Epidemiology Resource; MSK, Memorial Sloan Kettering; NNM, nearest neighbor matching; Q, quartile.